Connecticut Children's Medical Center
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Connecticut Children's Medical Center sits in the top decile of US sponsors by registered trial count (#348 of 15,742 sponsors by registered trial count).
Connecticut Children's Medical Center: 55 sponsored US clinical trials, 15 recruiting.
Connecticut Children's Medical Center sponsors 55 registered US clinical trials on ClinicalTrials.gov, 15 of them currently recruiting, and 35 completed. 6 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Glycogen Storage Disease Type Ia, with 2 trials.
Top-decile sponsor footprint
Connecticut Children's Medical Center ranks in the top decile of sponsors by registered trial count (#348 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
35 of 36 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (97.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
55 total, page 1 of 2
Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease
NCT07459582
Interoceptive Awareness and Function in Adolescents With Chronic Pain
NCT07325110
Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD
NCT07224113
Accuracy of Lactate Meter in GSDIa
NCT06843330
Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention
NCT06982066
Echography-guided Surfactant THERapy (ESTHER) For Preterm Infants With Respiratory Failure
NCT06446453
Utility of PCD Diagnostics to Improve Clinical Care
NCT05889013
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
NCT05781152
The Impact of Blood Flow Restriction Training in Adolescents After ACL Reconstruction: A Randomized Controlled Trial
NCT05754632
Subpectoral Bupivacaine for Pain Management in Adolescent Reduction Mammaplasty
NCT05898087
OSA-18 in Children With Mild Obstructive Sleep Apnea: Can it be a Helpful Decision Making Tool?
NCT05911646
Pain and Weight Treatment: Development and Trial of PAW
NCT04046562
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
NCT02530073
Quality of Life in Pediatric Patients With Acute Lymphoblastic Leukemia Receiving Maintenance Chemotherapy
NCT03132948
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
NCT00209235
ATOMIC Mobile App to Increase Physical Activity (PA) Levels in Survivors of Childhood Cancer
NCT05792566
Pediatric Speech Therapy Session Frequency and Speech Outcomes
NCT05900180
Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease
NCT07540767
Improving Sexual and Reproductive Health Communication for Adolescent and Young Adult Oncology Patients
NCT07658937
Application of Virtual Reality in Post-Operative Recovery of a Pediatric Scoliosis Patient Population
NCT06101264
Furosemide Use to Fill the Bladder of Pediatric Females Awaiting Pelvic Ultrasound
NCT05098366
Blood Flow Restriction Training (BFR) in an Adolescent Population
NCT04285879
Feasibility and Acceptability of the Propeller Monitoring System in Children With Persistent Asthma
NCT03648450
Studying the Influence of Exposure to Maternal Voice on Oral Feeding Volumes in Preterm Infants
NCT05181020
Monitoring Serologic Response to Severe Acute Respiratory Syndrome-2 (SARS-COV-2)/COVID-19 in Children
NCT04838834
Accuracy of Pediatric Emergency Medicine Providers in Diagnosing Hip Effusions Using Point of Care Ultrasound
NCT05971745
The Study is Enrolling Kids From 8 to 17 Years Old. The BreathSmart Device Attaches to the Inhaler to Measure Adherence.
NCT03734861
Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease
NCT02984059
Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy
NCT04036032
Yoga Intervention to Improve Pediatric Cancer Patients' Sleep & Life Quality and Parents' Well-Being
NCT02899117
Safety and Tolerability of Serum Derived Bovine Immunoglobulin in Children With Diarrhea Predominant IBS
NCT02358694
Web-MAP Intervention for Youth With Sickle Cell Disease
NCT02511769
Early Childhood Obesity Prevention Program
NCT02052518
Magnetic Resonance Imaging:A Window to Anthracycline Toxicity
NCT03211520
Is Univalving or Bivalving of Long Arm Casts for Forearm Fractures Necessary?
NCT02614690
Predicting Response to Standardized Pediatric Colitis Therapy
NCT01536535
The Added Value of Telephone Follow Up and Home Visits in Helping Children to Grow Up Healthy
NCT01973153
Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy
NCT01671696
Video Discharge Instructions for Fever and ED Recidivism
NCT01655251
Assessing Response to Albuterol in Bronchiolitis
NCT01238445
The Genetics of Respiratory Failure in Bronchiolitis
NCT01271491
Prospective Pediatric Vesicoureteral Reflux Surgery Database
NCT01373385
Psychometric Evaluation of the IPPAQ in Pediatric Patients With Sickle Cell Disease Hospitalized With Vasoocclusive Pain
NCT01058473
The Genetics of Severe Asthma in Children
NCT01238432
Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
NCT00863070
Prospective Pediatric Pyeloplasty Robotic Surgical Database
NCT00882544
Validation of the Sickle Cell Disease Pain Burden Interview
NCT00804362
Low-Dose Ketamine Infusion for Children With Sickle Cell Disease-Related Pain
NCT00595530
Assessing Function in Pediatric Patients With Sickle Cell Disease
NCT00590148
Genetic Influences of Albuterol Response In Children With Bronchiolitis
NCT00570297
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 4 | 6 |
Where Connecticut Children's Medical Center enrollment is open (later-stage tilt)
15 recruiting of 55 indexed (27% open); 35 completed (64%).
Phase mix: 6 late (III/IV) vs 2 early (I/II) (later-stage heavy).
Top condition: Glycogen Storage Disease Type Ia (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Connecticut Children's Medical Center: open-pipeline peers nationwide
Peers matched on 55 registered trials and 27% open enrollment, not the therapeutic-area sidebar.
Connecticut Children's Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 55 trials (± recruiting share)
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center · 55 trials · 2% recruiting
- Radicle Science · 55 trials · 7% recruiting
- Lexicon Pharmaceuticals · 56 trials · 2% recruiting
- AdventHealth Translational Research Institute · 54 trials · 24% recruiting
Sponsors near 27% open enrollment (± trial volume)
- Criterium · 27% recruiting · 11 trials
- Minneapolis Heart Institute Foundation · 27% recruiting · 22 trials
- Nerviano Medical Sciences · 27% recruiting · 11 trials
- Neuronetics · 27% recruiting · 11 trials
Related
What to do with this Connecticut Children's Medical Center page
55 registered trials is a research-attention snapshot, not an endorsement of Connecticut Children's Medical Center or any single study.
- 15 of Connecticut Children's Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Glycogen Storage Disease Type Ia is the condition Connecticut Children's Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Glycogen Storage Disease Type Ia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Connecticut Children's Medical Center pipeline card: 55 registered trials from official public datasets.Report a data error.